The B-cell Receptor Autoantigen LRPAP1 Can Replace Variable Antibody Regions to Target Mantle Cell Lymphoma Cells-Reference-Cited by-同舟云学术

The B-cell Receptor Autoantigen LRPAP1 Can Replace Variable Antibody Regions to Target Mantle Cell Lymphoma Cells

Published:2021-07-13 Issue:8 Volume:5 Page:e620
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Bewarder Moritz,Kiefer Maximilian,Will Helene,Olesch Kathrin,Moelle Clara,Stilgenbauer Stephan,Christofyllakis Konstantinos,Kaddu-Mulindwa Dominic,Bittenbring Joerg Thomas,Fadle Natalie,Regitz Evi,Kaschek Lea,Hoth Markus,Neumann Frank,Preuss Klaus-Dieter,Pfreundschuh Michael,Thurner Lorenz

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference41 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms.;Swerdlow;Blood,2016

2. Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK’s Haematological Malignancy Research Network.;Smith;Br J Cancer,2015

3. Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.;Hermine;Lancet,2016

4. Rituximab after autologous stem-cell transplantation in mantle-cell lymphoma.;Le Gouill;N Engl J Med,2017

5. Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study.;Dreyling;Lancet,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of novel prognostic autoantibodies in diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high‐throughput antigen microarray;Cancer;2023-12-22

2. Ars2‐containing bispecific, Fab‐ and IgG1‐format BAR‐bodies to target DLBCL cells;eJHaem;2022-12-27

3. Ligand-based CAR-T cell: Different strategies to drive T cells in future new treatments;Frontiers in Immunology;2022-09-12

4. Preparation and Synergistic Anti-Tumor Effect of Iridium Oxide Nanocomposites under Microscope;International Journal of Analytical Chemistry;2022-07-13

5. Autoantibodies against SUMO1-DHX35 in long-COVID;Journal of Translational Autoimmunity;2022